Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
China
· Delayed Price · Currency is CNY 31.96
-0.41 (-1.27%)
Mar 11, 2026, 3:04 PM CST
SHE:301130 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Net Income | 39.35 | 40.27 | 50.5 | 40.72 | 52.02 | 49.74 | Upgrade
|
| Depreciation & Amortization | 22.53 | 22.53 | 18.6 | 18.49 | 18.71 | 20.46 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.5 | 0.5 | -1.87 | - | - | 0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0 | 0 | 0.17 | 0 | 0.17 | 0 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5 | -5 | -10.92 | -6.71 | -1.21 | -1.97 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.64 | 0.64 | -0.54 | -0.05 | 0.31 | -0.1 | Upgrade
|
| Other Operating Activities | -5.95 | 0.7 | 0.84 | 0.35 | 0.01 | 0.03 | Upgrade
|
| Change in Accounts Receivable | -8.05 | -8.05 | 11.78 | 2.03 | -1.02 | 0.54 | Upgrade
|
| Change in Inventory | -0.24 | -0.24 | -7.43 | 5.61 | -6.48 | 1.47 | Upgrade
|
| Change in Accounts Payable | 3.97 | 3.97 | -4.39 | 9.53 | -0.67 | -3.19 | Upgrade
|
| Change in Other Net Operating Assets | - | - | -3.08 | -3.08 | -3.08 | -3.08 | Upgrade
|
| Operating Cash Flow | 46.67 | 54.24 | 54.39 | 67.23 | 59.01 | 64.54 | Upgrade
|
| Operating Cash Flow Growth | -32.69% | -0.26% | -19.10% | 13.92% | -8.57% | -2.11% | Upgrade
|
| Capital Expenditures | -62.46 | -134.97 | -123.17 | -54.4 | -21.18 | -14.51 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 2.6 | - | - | - | Upgrade
|
| Cash Acquisitions | -78.61 | -78.61 | - | - | - | - | Upgrade
|
| Investment in Securities | 49.21 | 129 | 202 | -347 | 1 | -16 | Upgrade
|
| Other Investing Activities | 4.4 | 7.02 | 8.94 | 6.99 | 2.12 | - | Upgrade
|
| Investing Cash Flow | -87.46 | -77.57 | 90.37 | -394.41 | -18.06 | -30.51 | Upgrade
|
| Long-Term Debt Repaid | - | -0.34 | -0.24 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.34 | -0.34 | -0.24 | - | - | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 412.56 | - | - | Upgrade
|
| Repurchase of Common Stock | -100.01 | -100.01 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -20.23 | -20.02 | -12.93 | -10.5 | - | -24.24 | Upgrade
|
| Other Financing Activities | 93.45 | - | - | -20.72 | -0.06 | -4.01 | Upgrade
|
| Financing Cash Flow | -27.13 | -120.37 | -13.17 | 381.33 | -0.06 | -28.25 | Upgrade
|
| Net Cash Flow | -67.92 | -143.69 | 131.59 | 54.15 | 40.89 | 5.78 | Upgrade
|
| Free Cash Flow | -15.79 | -80.73 | -68.79 | 12.83 | 37.83 | 50.03 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -66.09% | -24.39% | -5.05% | Upgrade
|
| Free Cash Flow Margin | -6.25% | -31.49% | -30.51% | 5.02% | 13.24% | 17.47% | Upgrade
|
| Free Cash Flow Per Share | -0.21 | -1.04 | -0.85 | 0.17 | 0.62 | 0.83 | Upgrade
|
| Cash Income Tax Paid | 31.94 | 29.86 | 40.07 | 34.51 | 43.56 | 46.28 | Upgrade
|
| Levered Free Cash Flow | -34.66 | -86.58 | -73.11 | 2.44 | 15.27 | 26.5 | Upgrade
|
| Unlevered Free Cash Flow | -34.43 | -86.53 | -73.08 | 2.44 | 15.27 | 26.5 | Upgrade
|
| Change in Working Capital | -5.4 | -5.4 | -2.39 | 14.43 | -11 | -3.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.